{
    "topic": "healthcare",
    "source": "Fox News",
    "bias": 2,
    "url": "http://www.foxnews.com/politics/2018/05/11/trump-vows-to-lower-us-drug-prices-by-ending-global-freeloading-taking-on-industry.html",
    "title": "Trump vows to lower US drug prices by ending \u2018global freeloading,\u2019 taking on industry",
    "date": "2018-05-11",
    "authors": "Alex Pappas",
    "content": "President Trump on Friday unveiled his administration \u2019 s plan for lowering prescription drug prices , vowing to \u201c take on \u201d the powerful pharmaceutical industry while calling for an end to \u201c global freeloading \u201d that has allowed foreign countries to pay less for American medicine .\n\u201c America will not be cheated any longer , and especially will not be cheated by foreign countries , \u201d Trump said Friday in a Rose Garden address .\nTrump said Americans , through higher drug prices at home , are essentially subsidizing the \u201c enormous cost of research and development \u201d for the benefit of other countries getting those drugs for cheap .\n\u201c In some cases , medicine that costs a few dollars in a foreign country costs hundreds of dollars in America for the same pill , with the same ingredients , in the same package , made in the same plant , \u201d Trump said . \u201c That is unacceptable . \u201d\nSaid Trump , \u201c It 's unfair . It 's ridiculous . It 's not going to happen any longer . It 's time to end the global freeloading once and for all . \u201d\nTrump said he 's directing his top trade official to correct this `` injustice '' with U.S. trading partners .\nTrump 's \u201c American Patients First \u201d blueprint includes several other tactics for lowering notoriously high drug prices in the U.S .\nThe plan calls for increasing competition , creating incentives for drugmakers to lower initial prices and slashing federal rules that make it harder for private insurers to negotiate lower prices .\n\u201c Today my administration is launching the most sweeping action in history to lower the price of prescription drugs for the American people , \u201d Trump said .\nThe president also had tough words for America \u2019 s pharmaceutical industry , saying he plans to \u201c take on one of the biggest obstacles to affordable medicine , the tangled web of special interests . \u201d\n\u201c The drug lobby is making an absolute fortune at the expense of American consumers , \u201d he said . \u201c No industry spends more money on lobbying than the pharmaceutical health products industry . \u201d\nTop officials at the Department of Health and Human Services also focused on the imbalance between drug prices at home and overseas , writing in a \u2588\u2588\u2588 op-ed that \u201c foreign countries and their government-run health-care systems bully our drug manufacturers into unrealistically low prices , allowing other countries to freeload off of American innovation . \u201d\n\u201c Americans should be able to reap the rewards of living in the country that has brought the world more new drugs than any other , \u201d wrote HHS Secretary Alex Azar , Food and Drug Administration Commissioner Scott Gottlieb and Centers for Medicare & Medicaid Services Administrator Seema Verma .\nHHS SECRETARY , FDA COMMISSIONER , CMS ADMINISTRATOR : HELP IS ON THE WAY FOR AMERICANS FACING HIGH DRUG PRICES\nTrump \u2019 s plan , though , will not include giving the federal Medicare program power to directly negotiate prices with drugmakers . Trump campaigned on the idea , which is vigorously opposed by the pharmaceutical industry .\n\u201c Instead of putting forth a bold initiative , the president pulled his punch , \u201d House minority leader Nancy Pelosi , D-Calif. , said in a statement . \u201c The president is breaking his promise to the American people to allow Medicare to negotiate lower drug prices , which would save seniors billions of dollars at the pharmacy . \u201d\nPublic outrage over drug costs has been growing for years , because Americans are being squeezed in a number of ways : New medicines for cancer and other life-threatening diseases often launch with prices exceeding $ 100,000 per year . Drugs for common ailments like diabetes and asthma routinely see price hikes around 10 percent annually . Meanwhile some companies have been buying up once-cheap older drugs and hiking prices by 1,000 percent or more .",
    "content_original": "President Trump on Friday unveiled his administration\u2019s plan for lowering prescription drug prices, vowing to \u201ctake on\u201d the powerful pharmaceutical industry while calling for an end to \u201cglobal freeloading\u201d that has allowed foreign countries to pay less for American medicine.\n\n\u201cAmerica will not be cheated any longer, and especially will not be cheated by foreign countries,\u201d Trump said Friday in a Rose Garden address.\n\nTrump said Americans, through higher drug prices at home, are essentially subsidizing the \u201cenormous cost of research and development\u201d for the benefit of other countries getting those drugs for cheap.\n\n\u201cIn some cases, medicine that costs a few dollars in a foreign country costs hundreds of dollars in America for the same pill, with the same ingredients, in the same package, made in the same plant,\u201d Trump said. \u201cThat is unacceptable.\u201d\n\nSaid Trump, \u201cIt's unfair. It's ridiculous. It's not going to happen any longer. It's time to end the global freeloading once and for all.\u201d\n\nTrump said he's directing his top trade official to correct this \"injustice\" with U.S. trading partners.\n\nTrump's \u201cAmerican Patients First\u201d blueprint includes several other tactics for lowering notoriously high drug prices in the U.S.\n\nThe plan calls for increasing competition, creating incentives for drugmakers to lower initial prices and slashing federal rules that make it harder for private insurers to negotiate lower prices.\n\n\u201cToday my administration is launching the most sweeping action in history to lower the price of prescription drugs for the American people,\u201d Trump said.\n\nThe president also had tough words for America\u2019s pharmaceutical industry, saying he plans to \u201ctake on one of the biggest obstacles to affordable medicine, the tangled web of special interests.\u201d\n\n\u201cThe drug lobby is making an absolute fortune at the expense of American consumers,\u201d he said. \u201cNo industry spends more money on lobbying than the pharmaceutical health products industry.\u201d\n\nTop officials at the Department of Health and Human Services also focused on the imbalance between drug prices at home and overseas, writing in a Fox News op-ed that \u201cforeign countries and their government-run health-care systems bully our drug manufacturers into unrealistically low prices, allowing other countries to freeload off of American innovation.\u201d\n\n\u201cAmericans should be able to reap the rewards of living in the country that has brought the world more new drugs than any other,\u201d wrote HHS Secretary Alex Azar, Food and Drug Administration Commissioner Scott Gottlieb and Centers for Medicare & Medicaid Services Administrator Seema Verma.\n\nHHS SECRETARY, FDA COMMISSIONER, CMS ADMINISTRATOR: HELP IS ON THE WAY FOR AMERICANS FACING HIGH DRUG PRICES\n\nTrump\u2019s plan, though, will not include giving the federal Medicare program power to directly negotiate prices with drugmakers. Trump campaigned on the idea, which is vigorously opposed by the pharmaceutical industry.\n\nDemocrats hit him over the issue Friday.\n\n\u201cInstead of putting forth a bold initiative, the president pulled his punch,\u201d House minority leader Nancy Pelosi, D-Calif., said in a statement. \u201cThe president is breaking his promise to the American people to allow Medicare to negotiate lower drug prices, which would save seniors billions of dollars at the pharmacy.\u201d\n\nPublic outrage over drug costs has been growing for years, because Americans are being squeezed in a number of ways: New medicines for cancer and other life-threatening diseases often launch with prices exceeding $100,000 per year. Drugs for common ailments like diabetes and asthma routinely see price hikes around 10 percent annually. Meanwhile some companies have been buying up once-cheap older drugs and hiking prices by 1,000 percent or more.\n\nFox News\u2019 Laquasha Banks, Mike Emanuel and Kristin Brown and The Associated Press contributed to this report.",
    "source_url": "www.foxnews.com",
    "bias_text": "right",
    "ID": "rB8uHG0DpMVT9GWg"
}